-

CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into CareDx, Inc. (NasdaqGM: CDNA).

CareDx provides medical services and tests for transplant recipients with notable products AlloSure, AlloMap, and RemoTraC. On October 28, 2021, the Company disclosed that it was the subject of two federal investigations by the U.S. Department of Justice (DOJ) and the SEC relating to “certain business practices related to [the Company’s] kidney testing and phlebotomy services.” On May 23 and September 1, 2022, the Company disclosed the resignation of its CFO, Ankur Dhingra, along with its chief marketing officer and chief commercial officer, Sasha King, respectively. In November 2022, the Company disclosed lackluster overall revenue growth, including a $1.7 million (2.5%) YOY decline in revenue from its diagnostic solutions segment, as well as a 14% increase in operating costs, exceeding the increase in revenue, and that loss from operations nearly doubled from $8.7 to $17.3 million.

The Company has been sued in a securities class action lawsuit for failing to disclose material information, violating federal securities laws. Previously, the court denied the Company’s motion to dismiss the case in part, allowing the case to continue. Recently, the court again denied the Company’s motion to dismiss the Third Amended Complaint.

KSF’s investigation is focusing on whether CareDx’s officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.

If you have information that would assist KSF in its investigation, or have been a long-term holder of CareDx shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgm-cdna/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

Kahn Swick & Foti, LLC

NASDAQ:CDNA

Release Versions

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

More News From Kahn Swick & Foti, LLC

ON24 Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ON24, Inc. - ONTF

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ON24, Inc. (NYSE: ONTF) to Cvent. Under the terms of the proposed transaction, shareholders of ON24 will receive $8.10 in cash for each share of ON24 that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration underv...

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Day One Biopharmaceuticals, Inc. (NasdaqGS: DAWN) to Servier. Under the terms of the proposed transaction, shareholders of Day One will receive $21.50 in cash for each share of Day One that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate,...

Flushing Financial Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Flushing Financial Corp. - FFIC

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Flushing Financial Corp. (NasdaqGS: FFIC) to OceanFirst Financial Corp. (NasdaqGS: OCFC). Under the terms of the proposed transaction, shareholders of Flushing Financial will receive 0.85 of a share of OceanFirst common stock for each share of Flushing Financial that they own. KSF is seeking to dete...
Back to Newsroom